404 related articles for article (PubMed ID: 11170906)
21. Fluconazole resistance of Candida krusei.
Manso E; Montillo M; Discepoli G; Leoni P
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
[TBL] [Abstract][Full Text] [Related]
22. Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Cancelas JA; Lopez J; Cabezudo E; Navas E; Garcia Laraña J; Jimenez Mena M; Diz P; Perez de Oteyza J; Villalon L; Sanchez-Sousa A
Bone Marrow Transplant; 1994 Mar; 13(3):333-4. PubMed ID: 8199575
[TBL] [Abstract][Full Text] [Related]
23. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
Tokimatsu I; Kushima H; Hashinaga K; Umeki K; Ohama M; Ishii H; Kishi K; Hiramatsu K; Kadota J
Int J Antimicrob Agents; 2007 Jan; 29(1):84-8. PubMed ID: 17189098
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
25. A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
Wilson AG; Micek ST; Ritchie DJ
Clin Ther; 2005 Aug; 27(8):1228-37. PubMed ID: 16199247
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
27. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
[TBL] [Abstract][Full Text] [Related]
28. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
29. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Candida tropicalis fungemia in patients with cancer.
Kontoyiannis DP; Vaziri I; Hanna HA; Boktour M; Thornby J; Hachem R; Bodey GP; Raad II
Clin Infect Dis; 2001 Nov; 33(10):1676-81. PubMed ID: 11568858
[TBL] [Abstract][Full Text] [Related]
31. [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].
Manabe A; Ebihara Y; Saito A; Takahashi K; Hosoya R
Rinsho Ketsueki; 1997 Aug; 38(8):669-73. PubMed ID: 9311273
[TBL] [Abstract][Full Text] [Related]
32. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
33. Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
Drugs Exp Clin Res; 1999; 25(4):193-200. PubMed ID: 10442277
[TBL] [Abstract][Full Text] [Related]
34. Disseminated infection due to Candida guilliermondii in a patient with AML(M4). Case study.
Pânzaru C; Dan M; Burcoveanu C; Mereuţă A; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):727-30. PubMed ID: 17571574
[TBL] [Abstract][Full Text] [Related]
35. Candida krusei fungemia. Report of 4 cases and review of the literature.
Goldman M; Pottage JC; Weaver DC
Medicine (Baltimore); 1993 May; 72(3):143-50. PubMed ID: 8502167
[TBL] [Abstract][Full Text] [Related]
36. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for breakthrough candidemia.
Nucci M; Colombo AL
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):209-11. PubMed ID: 11957023
[TBL] [Abstract][Full Text] [Related]
39. Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Odds FC
Clin Infect Dis; 2003 May; 36(10):1229-31. PubMed ID: 12746766
[No Abstract] [Full Text] [Related]
40. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
